The Research Strategy
In accordance with our commitment as a University Department, the Department of Haematology at Aalborg Hospital has a research programme with focus on one or several aspects of the clinical courses of our patients as described in our “A regional translational research programme for malignant B cell disorders”.
Main Project Area
- Cancer stem cells in lymphoma and multiple myelomas
- Murine models of lymphomagenesis
- MicroRNAs in initiation and development of B cell lymphomas
- Impact of genetic lesions and mutations (SNP chip, GEP)
- Individualized chemosensitivity prediction
- Clinical trials
Ongoing PhD Programmes
- Targeting multidrug resistance mechanisms in Diffuse Large B-cell Lymphoma
- Late toxicities of steroid-including immunochemotherapy regimens for patients with lymphoma
- Long-term complications following treatment for haematological malignancies: Neuropathy and Cognitive Impairment
- Decision Support Tools for Precision Oncology
- Impact of genetic variations on molecular subtypes and outcome of DLBCL
- Socioeconomic impact, late toxicities and long-term outcomes following treatment for haematological cancers
Ongoing Scholarships
- Angst og depression hos patienter med akut myeloid leukæmi: et nationalt registerstudie
- The impact of Cisplatin on DNA damage response in DLBCL
Web-links
Aarhus University (Aarhus Universitet)
Aalborg University Hospital Science and Innovation Center (Forskningens Hus)
Departments of Haematology in DK
Aalborg University Hospital
H:S Rigshospitalet
Odense University Hospital (Odense Universitetshospital)
KAS Herlev
Aarhus Hospital (Århus Sygehus)
Organisations
Dansk Hæmatologisk Selskab
Nordic Myeloma Study Group